Corporate development in biotechnology in 2005

A Williams - Journal of commercial biotechnology, 2005 - Springer
In 1998 the author produced two papers which argued that consolidation was a necessary
activity for biotechnology companies to consider more. Three years later a further …

Biotech meets the investors

S Berry - Trends in biotechnology, 2002 - cell.com
Biotech meets the investors: Trends in Biotechnology Skip to Main Content Advertisement
Trends in Biotechnology This journal offers authors two options (open access or subscription) …

[引用][C] Biotechnology priorities, planning and policies: a frame work for decision making. A biotechnology research management study

JI Cohen - 1994 - ISNAR Research Report No. 6. The …

Voices of biotech leaders

AE Abong, K Bosley, C Casebourn, P Chan… - Nature …, 2021 - research.rug.nl
University of Groningen Voices of biotech leaders Abong, Abasi Ene; Bosley, Katrine;
Casebourn, Charlotte; Chan, Priscilla; Chen Page 1 University of Groningen Voices of biotech …

Entrepreneurship for biotechnology ventures: From bench to bag

DW Altman - Plant Development and Biotechnology, 2004 - books.google.com
Now that you have come up with the greatest innovation the plant tissue culture and
biotechnology universe has ever seen, what can you do to make sure that it gets into the …

An analysis of firm-level innovation strategies in the US biotechnology industry

LA Hall, S Bagchi-Sen - Technovation, 2007 - Elsevier
This study examines factors that may affect innovation strategies and performance of firms in
the biotechnology industry. Specifically, differences between factors common to firms with …

[引用][C] Biotech 89: Commercialization: Third Annual Survey of Business and Financial Issues in America's Most Promising Industry

GS Burrill - 1988 - Mary Ann Liebert

[PDF][PDF] Value creation and investor performance of the Australian drug development biotech sector

P Molloy - 2019 - researchbank.swinburne.edu.au
Australia has long been lauded as a biotechnology leader and consistently been ranked in
the top five biotechnology nations worldwide, based on the Scientific American Worldview …

Understanding biotechnology business models and managing risk

C Shimasaki - Biotechnology Entrepreneurship, 2014 - Elsevier
Every commercial enterprise operates with an underlying business model, whether
purposefully decided or arrived at by default—biotechnology companies included. Business …

Biotech sector ponders potential'bloodbath'.

P Mitchell - Nature Biotechnology, 2009 - search.ebscohost.com
The article discusses how the stressed global economy has resulted in a lack of lending and
funding opportunities for small public biotechnology companies. As many of these …